Biotech Startups

MasterControl provides an integrated software platform for life sciences manufacturers that combines quality management, manufacturing execution, and asset management with built-in AI and business intelligence capabilities.

1 investor

Materia Bioworks develops MAPS, an AI-powered platform for accelerating product development using bio-based and biodegradable materials. The system helps manufacturers and product developers optimize material formulations and explore sustainable material options to reduce R&D cycles.

1 investor

Material Futures develops all-natural colours produced by microorganisms.

1 investor

Materia Medica Processing is an Italian pharmaceutical company authorized by the Ministry of Health to distribute and produce cannabis-derived active pharmaceutical ingredients (APIs) for medical use, supplying pharmacies for magistral preparations under medical prescription. Operating GMP laboratories, it imports plant substances and extracts from qualified European suppliers and serves pharmacies, physicians, and patients.

1 investor

Mati makes plant-based meat alternatives such as a chicken substitute made from mycelium (mushroom root structure) grown through fermentation, high in protein and fiber. Its products are marketed as sustainable food that suits any dish or world cuisine, with additional items like a fish alternative in development.

1 investor

Matrubials develops antimicrobial peptides derived from milk to create novel therapeutics for bacterial infections, starting with bacterial vaginosis. The company uses AI-enabled technology to identify and validate bioactive molecules for infectious disease treatments.

1 investor

Matwings is an AI-driven protein research platform that combines large-scale protein sequence datasets with a proprietary large language model for precise functional protein design. The platform automates the entire workflow from drug discovery and agricultural applications to biofabricated materials, serving pharmaceutical, biotechnology, and agribusiness sectors.

1 investor

Maven Bio provides software for biotech investment firms to accelerate due diligence and thesis development, automating screening, competitive analysis, and clinical data review to compress research timelines from days to hours.

1 investor

Mavios provides an AI-native platform that integrates deep bioprocess knowledge and unified intelligence to bridge the gap between biological research capabilities and large-scale industrial production. The platform serves biomanufacturing teams working on food, health, materials, and medicine innovations.

1 investor

1 investor

Maya Milk engineers and optimizes microbial yeast strains for precision fermentation, enabling food companies to produce animal-free dairy proteins and fats such as whey protein. It serves dairy and alternative-protein producers in the foodtech industry, with R&D operations in Izmir, Turkey.

1 investor

1 investor

mbiomics designs and develops complex Live Biotherapeutic Products (LBPs) based on gut microbiome consortia to treat severe and chronic diseases, with a pipeline spanning oncology (melanoma, NSCLC/renal cell carcinoma), IBD, and ASD. The company combines a data science platform, a proprietary strain library, co-culturing manufacturing, and screening analytics to design and produce indication-specific microbial therapeutics.

1 investor

mBrace Therapeutics is a therapeutics company focused on drug development, led by executives with backgrounds in oncology and pharmaceutical business development.

1 investor

MBX Capital is an investment firm that backs companies in the "Deep Health" space, with a portfolio spanning biotech, therapeutics, diagnostics, and life sciences tooling.

1 investor

MC Sciences is a biotech company developing first-in-class mast cell therapeutics based on a discovered mast cell receptor, aimed at diseases across immunology, dermatology, respiratory, gastrointestinal, fibrotic and chronic inflammatory conditions such as chronic urticaria, systemic mastocytosis, COPD, asthma and MCAS. It develops both small- and large-molecule drugs and is headquartered in Germany with operations in Naples, Florida.

1 investor

Biotechnology company developing treatments for ophthalmic diseases, focusing on dry eye through a topical ophthalmology platform.

1 investor

UT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.

1 investor

1 investor

1 investor

MeCo Diagnostics develops diagnostic solutions for cancer detection and management. The company works with healthcare institutions and oncology professionals to improve patient outcomes.

1 investor

Meddenovo develops Mexa, an AI-powered platform for de novo design of cyclic peptide drug candidates. The company serves pharmaceutical partners seeking to discover novel peptide therapeutics for oncology, radiopharmaceuticals, and metabolic diseases.

1 investor

Medical Excellence Capital is a venture capital firm investing in early-stage life science and healthcare companies. The fund focuses on biotech, therapeutics, diagnostics, and medical device innovations, and is founded by and operates for patient benefit in the healthcare sector.

1 investor

Medexus Pharmaceuticals is a specialty pharmaceutical company focused on orphan drugs and rare disease treatments, with a portfolio of specialty and rare disease products. It operates a fully integrated North American business model spanning commercial operations, supply chain, regulatory, medical affairs, and sales.

1 investor